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Figure 2: Effect of in vivo Ang II administration on LV
contractions ex vivo. Representative LV diameter traces for (A)
control rat and (B) Ang II treated rat.
Methods
Hypertension (elevated blood pressure) is a risk factor for
lymphedema after cancer treatment. Lymphedema is the fluid
accumulation in the interstitial tissues due to impaired lymph flow.
Lymph flow critically relies on spontaneous rhythmic contractions of
lymph vessels (LVs) to maintain the interstitial fluid balance. Thus,
evaluation of lymphatic contractions during hypertension is
important to understanding the predisposition of cancer patients to
lymphedema. Angiotensin II (Ang II) is a key regulator of blood
pressure and potent vasoconstrictor. Ang II levels are elevated
during hypertension, resulting in vasoconstriction, increased
peripheral resistance, and increased afterload. However, the effect
of Ang II mediated hypertension on lymphatic contractile function is
unknown. Here, we evaluated how in-vivo Ang II administration
modified the rhythmic contractions of isolated LVs ex-vivo. Ang II
containing osmotic mini pumps (500 ng/kg/min) were implanted
subcutaneously in male Sprague Dawley rats for 14 days. Isolated
rat mesenteric LVs were cannulated and pressurized (4-5 mmHg)
in a perfusion bath containing physiological salt solution (PSS).
Real-time edge detection software tracked changes in diameter.
Rhythmic contractions were recorded for ~45 minutes and then
nifedipine (1 µmol/L) was added to the bath for 10 mins followed by
washout with calcium free PSS. LVs isolated from Ang II infused
rats (n=8) had significantly increased calcium dependent tone to
14.3% ± 5.1% compared to age-matched controls (n=8) which
remained at 5.2% ± 1.1%. LVs from Ang II treated animals also
exhibited a larger response to nifedipine (n=6) with 10.8% ± 5.6%
increase in dilation compared to control LVs (n=8). Contractile
traces showed visible dysrhythmia in LVs isolated from Ang II
infused animals corresponding to a wider variation in time intervals
between two consecutive contractions. Our findings suggest that
Ang II mediated hypertension can lead to lymphatic contractile
dysfunction, which may be a potential mechanism by which
hypertension increases the risk of lymphedema.
Summary
➢ Ang II mediated hypertension induced contractile
dysrhythmia in isolated LVs.
➢ LVs isolated from Ang II treated rats exhibited increased
calcium dependent tone.
Future studies are needed to determine the molecular mechanism
underlying this lymphatic contractile dysfunction and whether Ang II
mediated hypertension alters lymph flow in vivo.
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Background
Abstract
The lymphatic system moves fluid from the interstitial spaces to the
bloodstream, with the help of lymph vessels (LVs) and maintains
the fluid homeostasis. Rhythmic contraction is the main propelling
force behind the transport of lymph fluid through the LVs, and any
kind of LV contractile dysfunction can lead to fluid accumulation in
the tissues, known as lymphedema. Hypertension is a risk factor
which gives rise to lymphedema after cancer treatment; however,
the effect of hypertension on LV contractility has not been fully
defined. Studies have shown that Ang II mediated hypertension
leads to increased Ca2+ tone and upregulation of L-type calcium
channels (LTCCs) in arteries resulting in decreased arterial
diameter. It is possible that hypertension results in similar changes
to LV contractility. The purpose of our study was to determine the
effect of Ang II mediated hypertension on LV diameter and rhythmic
contractions of rat mesenteric LVs.
Rats were placed in an induction chamber with an inflow of
isoflurane at a rate of 1.5-2%. An ~1 cm incision was created
behind the ear over the shoulder blade of the front leg to make a
subcutaneous tunnel. Ang II containing osmotic mini pumps (500
ng/kg/min) were then implanted subcutaneously in 9-13 weeks old
male Sprague Dawley (SD) rats for 14 days. Second order
mesenteric LVs were isolated and cannulated from Ang II treated
and age matched control rats. Vessels were pressurized to 4-5
mmHg and allowed to equilibrate in physiological saline solution
(PSS) at 37°C to allow spontaneous contractions to develop. Edge-
detection software (IonOptix) recorded changes in external
diameter. Spontaneous contractions were recorded for ~45 mins
followed by washout with calcium free PSS for 10 mins. In a
subset of LVs, nifedipine (NIF; 1 µmol/L) was added to the bath
prior to washout with calcium free PSS.
Figure 1: (A) Lymph vessel (LV), artery (Ar) and vein (V) in a rat
mesenteric loop. (B) Image of a cannulated LV; diameter is
measured by edge detection software.
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Figure 4: Ang II treated LVs exhibited increased Ca2+ dependent
tone. LVs isolated from Ang II treated rats had increased dilation in
response to calcium free PSS and nifedipine corresponding to an
increase in (A) global Ca2+ dependent tone and (B) tone mediated
by LTCCs. Data presented as mean ± SEM (n=6-8; p<0.05)
Methods
Figure 3: Dysrhythmic contractile pattern of LV corresponds to
a more varied contraction interval. (A) Manhattan plot showing
each interval between two consecutive contractions in individual
LVs. (B) LVs isolated from Ang II treated rats exhibited increased
variation in the standard deviation for contraction interval compared
to controls (n= 9-11).
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